Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>The alcoholic liver injury (ALI) commonly occurs among people, typically the young and the middle-aged, who drink heavily. The ALI is extremely harmful and can induce severe disease states such as hepatitis, liver fibrosis, cirrhosis or even liver cancer. Recent studies found that the pathological changes of hepatocytes and hepatic stellate cell showed significant connection between endoplasmic reticulum (ER) stress which is the key factor to aggravate the development of liver pathology in patients with ALI. However, the detailed mechanism needs to be further studied. <em>Schisandra chinensis</em>, a member of TCM, has been used as a Chinese folk medicine for treatments of chronic or acute diseases especially the liver diseases, and especially <em>Schisandra chinensis</em> (<em>S. chinensis</em>) derived lignans (SCDLs) have been shown to alleviate liver pathological changes.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>This study sought to elucidate the mechanisms underlying SCDLs-mediated hepatoprotection.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>We first used <em>in silico</em> target prediction and computational simulation methods to identify putative lignans binding targets relative to the hepatoprotective effect. The gene microarray analysis was also performed in this study to identify differently expressed genes which may have significance in disease pathological process; we then used histological analyses in a mice hepatotoxicity model to test the effectiveness of SCDLs in vivo, and hepatocellular toxicity model to analyze the candidate compound mediated hepatoprotection and expression states of the key targets in vitro.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p><em>In silico</em> analysis results showed endothelin receptor B (ETBR/EDNRB) is likely a significant node during the liver pathological change process and a promising key target for the SCDLs compound Schisantherin D on the hepatoprotective effect; experimental studies showed that Schisantherin D alleviated HL-7702 cell (belongs to liver parenchymal cell lines) injury ratio, decreased expression of ETBR, and inhibited ECMs and ET-1 secretion in LX-2 cells (one form of hepatic stellate cells); SCDLs ameliorated the fibrosis formation in mice liver tissue. Liver tissue western blots of SCDLs treated mice showed down-regulated α-SMA, ETBR, PLCβ, CHOP, Bax, and the apoptotic factors of cleaved-caspase 12, cleaved-caspase 9 and cleaved-caspase 3 indicating the anti-apoptosis and hepatoprotective effect. SCDLs treatment also elevated serum glutathione (GSH) and reduced serum transforming growth factor-β1 (TGF-β1) level.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>SCDLs appears to prevent hepatotoxicity by the anti-fibrotic, anti-oxidance, and anti-apoptosis properties. ETBR may be the key factor in EtOH induced long term liver degeneration.</p>

The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol

[Study on Main Pharmacodynamic Effects for Schisandra Lignans Based Upon Network Pharmacology].

Schisandrin B targets cannabinoid 2 receptor in Kupffer cell to ameliorate CCl4-induced liver fibrosis by suppressing NF-κB and p38 MAPK pathway

Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis

Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study

Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways

Lignans from Schisandra chinensis ameliorate alcohol and CCl4-induced long-term liver injury and reduce hepatocellular degeneration via blocking ETBR

Schisandrin B Attenuates CCl4-induced Liver Fibrosis in Rats by Regulation of Nrf2-ARE and TGF-β/Smad Signaling Pathways.

Lipophilic Constituents in Salvia miltiorrhiza Inhibit Activation of the Hepatic Stellate Cells by Suppressing the JAK1/STAT3 Signaling Pathway: A Network Pharmacology Study and Experimental Validation

Schisandrin B Attenuates Lipopolysaccharide-Induced Activation Of Hepatic Stellate Cells Through Nrf-2-Activating Anti-Oxidative Activity

Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice

Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury.

Protective Effect of Schisandra Chinensis Total Lignans on Acute Alcoholic-Induced Liver Injury Related to Inhibiting CYP2E1 Activation and Activating the Nrf2/ARE Signaling Pathway

Effects of total lignans from Tibetan medicine Herpetospermum pedunculosum seeds on proliferation and apoptosis of rat hepatic stellate cells

Correlation Between Antistress and Hepatoprotective Effects of Schisandra Lignans Was Related with Its Antioxidative Actions in Liver Cells

Schisandra Lignan Extract Protects Against Carbon Tetrachloride-Induced Liver Injury in Mice by Inhibiting Oxidative Stress and Regulating the NF-κB and JNK Signaling Pathways

Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPARγ

Schisandrin B promotes senescence of activated hepatic stellate cell via NCOA4-mediated ferritinophagy

Luteolin Alleviates Liver Fibrosis in Rat Hepatic Stellate Cell HSC-T6: A Proteomic Analysis

Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl4-induced liver fibrosis

Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation